Xylitol, Mitochondrial Plasticity, the Warburg Effect, and Oral Pathobiont-Associated Immune Evasion in Cancer Hypothesis.
Level 5 - mechanism / opinion, no new human data
Narrative review and hypothesis paper with no new human data
PubMed 42511476 · doi:10.3390/ijms27146130
What was done
This narrative review synthesizes literature on xylitol metabolism, mitochondrial plasticity, the Warburg effect, and oral pathobionts to formulate a hypothesis regarding xylitol's role as a metabolic modifier in cancer. The authors evaluated biochemical pathways (pentose phosphate, glucuronate-xylulose, and xylitol dehydrogenase metabolism) and interactions with oral pathogens (Fusobacterium nucleatum, Porphyromonas gingivalis, and Streptococcus mutans).
What was found
No quantitative data or effect sizes are reported in the abstract. Preclinical models cited showed that partially replacing glucose with xylitol decreased proliferation and glycolytic markers in oral squamous cell carcinoma, with reported links to glutathione depletion, endoplasmic reticulum stress, and autophagy-associated cell death. The authors also noted that xylitol's anti-adhesive actions might counter pathogen-promoted pro-tumorigenic senescence and immune evasion.
Why it matters
The paper presents an integrated theoretical framework connecting dietary polyols, host mitochondrial bioenergetics, and microbiome-driven immune evasion in oncology.
Limits
This is a hypothesis and narrative review containing no new clinical or human experimental data. All discussed anticancer and immunomodulatory effects are based on preclinical or theoretical models. In addition, the abstract notes unconfirmed safety signals linking high endogenous xylitol levels to adverse cardiovascular events, requiring further prospective evaluation.